Activated clotting time
Activated Clotting Time (ACT) is a medical test that is primarily used to monitor anticoagulation therapy for patients undergoing cardiac surgery and percutaneous coronary intervention (PCI). The test measures the time it takes for a patient's blood to clot after the addition of an activating agent.
Overview[edit | edit source]
The ACT test is a point-of-care test, meaning it can be performed and interpreted at the patient's bedside. It is a crucial tool in the management of patients who are on heparin therapy, as it allows for real-time monitoring of the anticoagulant's effect. The test is performed by adding an activating agent to a sample of the patient's blood and then measuring the time it takes for a clot to form.
Procedure[edit | edit source]
The ACT test is typically performed using a handheld device. A small sample of the patient's blood is drawn into a test tube, which contains an activating agent such as kaolin or celite. The tube is then placed into the device, which measures the time it takes for a clot to form. The result is expressed in seconds.
Clinical significance[edit | edit source]
The ACT test is primarily used to monitor the effectiveness of heparin therapy in patients undergoing procedures that require significant anticoagulation, such as cardiac surgery and PCI. The test allows for real-time adjustments to the heparin dose, ensuring that the patient remains adequately anticoagulated throughout the procedure.
In addition to its use in monitoring heparin therapy, the ACT test can also be used to assess a patient's overall coagulation status. Elevated ACT values can indicate a hypercoagulable state, while decreased values can suggest a bleeding disorder or coagulopathy.
Limitations[edit | edit source]
While the ACT test is a valuable tool in the management of patients on heparin therapy, it does have some limitations. The test is not specific for heparin and can be influenced by other factors that affect coagulation, such as platelet count, fibrinogen levels, and the presence of other anticoagulants. Additionally, the test does not provide information on the quality of the clot, only the time it takes for a clot to form.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD